recombinant human thrombopoietin
Term · Oncology and biomedicine · MLC-T-ONC-016427
A recombinantly produced form of human thrombopoietin (rHuTPO). rHuTPO stimulates platelet formation and has potential use as a therapeutic agent to prevent thrombocytopenia in patients receiving chemotherapy.
| Identifier | MLC-T-ONC-016427 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | rHuTPO |
| Synonyms | recombinant human TPO; megakaryocyte growth and development factor |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016427",
"term": "recombinant human thrombopoietin",
"field": "Oncology and biomedicine",
"definition": "A recombinantly produced form of human thrombopoietin (rHuTPO). rHuTPO stimulates platelet formation and has potential use as a therapeutic agent to prevent thrombocytopenia in patients receiving chemotherapy.",
"abbreviation": "rHuTPO",
"synonyms": [
"recombinant human TPO",
"megakaryocyte growth and development factor"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-human-thrombopoietin/"
}
Record 14,176 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.